MELISSA BARNETT: Open Payments
NPI 1669450425 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,462 in 37 payments from 9 companies in 2025. Trend: 2023 $18,649 · 2024 $16,255 · 2025 $5,462
Speaker / faculty: $4,908Food & beverage: $554
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 11 | $4,966 |
| Astellas Pharma US Inc | 10 | $233 |
| MILLICENT US INC | 5 | $82 |
| Exeltis, USA Inc. | 4 | $66 |
| ABBVIE INC. | 3 | $55 |
| Hologic Sales and Service, LLC | 1 | $25 |
| PFIZER INC. | 1 | $16 |
| Amgen Inc. | 1 | $15 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $5 |
Products named: NEXPLANON, Veozah, SLYND, INTRAROSA, FEMRING, ACESSA PROVU SYSTEM, QULIPTA, LILETTA.
Industry payments across MS — which companies pay providers there.
